Mohammad Hirmand - 27 Mar 2023 Form 4 Insider Report for Aadi Bioscience, Inc. (WHWK)

Role: Director
Signature: /s/ Stephen Rodin, as Attorney-in-Fact
Issuer symbol: WHWK
Transactions as of: 27 Mar 2023
Net transactions value: $0
Form type: 4
Filing time: 29 Mar 2023, 16:20:41 UTC
Previous filing: 17 Aug 2022
Next filing: 14 Jun 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AADI	Stock Option (right to buy)	Award	$0	+59,206		$0.000000	59,206	27 Mar 2023	Common Stock	59,206	$7.25	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one thirty-sixth (1/36th) of the shares subject to the option shall vest on a monthly basis following the grant date on the same day of the month as the grant date (and if there is no corresponding day, on the last day of the month) such that all shares subject to option shall be fully vested on the three year anniversary of the grant date. The grant date is March 27, 2023.

Content

Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one thirty-sixth (1/36th) of the shares subject to the option shall vest on a monthly basis following the grant date on the same day of the month as the grant date (and if there is no corresponding day, on the last day of the month) such that all shares subject to option shall be fully vested on the three year anniversary of the grant date. The grant date is March 27, 2023.